StockData
Wave Life Sciences, Inc. logo

Wave Life Sciences, Inc. (WVE) stock

WVENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 10/3046% below fair value
$2.84−0.03 (-1.05%)

Close on Nov 17, 2026Market cap $560.13MP/E –Yield –

Wave Life Sciences total assets

Total assets on the balance sheet at the end of each period.

Wave Life Sciences's total assets was $507.93M at Sep 30, 2026. For fiscal 2025 it was $638.50M, up 81.3% from the year before. Over ten years it grew 14.5% a year on average. The highest annual figure on record is $638.50M in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$638.50M+81.3%
FY2024Dec 31, 2024$352.21M+28.1%
FY2023Dec 31, 2023$274.95M+87.8%
FY2022Dec 31, 2022$146.39M-29.3%
FY2021Dec 31, 2021$207.01M-25.9%
FY2020Dec 31, 2020$279.24M-1.8%
FY2019Dec 31, 2019$284.25M-4.0%
FY2018Dec 31, 2018$295.94M+62.7%
FY2017Dec 31, 2017$181.84M+10.3%
FY2016Dec 31, 2016$164.81M-0.4%
FY2015Dec 31, 2015$165.42M+5530.5%
FY2014Dec 31, 2014$2.94M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$507.93M+110.4%
Q2 FY2026Jun 30, 2026$558.32M+121.2%
Q1 FY2026Mar 31, 2026$583.54M+102.4%
Q4 FY2025Dec 31, 2025$638.50M+81.3%
Q3 FY2025Sep 30, 2025$241.38M-32.7%
Q2 FY2025Jun 30, 2025$252.36M+20.8%
Q1 FY2025Mar 31, 2025$288.34M+22.6%
Q4 FY2024Dec 31, 2024$352.21M+28.1%
Q3 FY2024Sep 30, 2024$358.50M+79.3%
Q2 FY2024Jun 30, 2024$208.82M-9.2%
Q1 FY2024Mar 31, 2024$235.27M-12.0%
Q4 FY2023Dec 31, 2023$274.95M+87.8%
Q3 FY2023Sep 30, 2023$199.92M+10.1%
Q2 FY2023Jun 30, 2023$229.99M+7.8%
Q1 FY2023Mar 31, 2023$267.27M+59.7%
Q4 FY2022Dec 31, 2022$146.39M-29.3%
Q3 FY2022Sep 30, 2022$181.51M-9.5%
Q2 FY2022Jun 30, 2022$213.32M+3.3%
Q1 FY2022Mar 31, 2022$167.36M-31.0%
Q4 FY2021Dec 31, 2021$207.01M-25.9%
Q3 FY2021Sep 30, 2021$200.51M-35.3%
Q2 FY2021Jun 30, 2021$206.41M+1.2%
Q1 FY2021Mar 31, 2021$242.65M+1.7%
Q4 FY2020Dec 31, 2020$279.24M-1.8%
Q3 FY2020Sep 30, 2020$310.06M-10.7%
Q2 FY2020Jun 30, 2020$203.95M-47.1%
Q1 FY2020Mar 31, 2020$238.57M-44.6%
Q4 FY2019Dec 31, 2019$284.25M-4.0%
Q3 FY2019Sep 30, 2019$347.21M+7.0%
Q2 FY2019Jun 30, 2019$385.55M+9.0%
Q1 FY2019Mar 31, 2019$430.61M+186.3%
Q4 FY2018Dec 31, 2018$295.94M+62.7%
Q3 FY2018Sep 30, 2018$324.58M+60.6%
Q2 FY2018Jun 30, 2018$353.74M+56.2%
Q1 FY2018Mar 31, 2018$150.42M-0.7%
Q4 FY2017Dec 31, 2017$181.84M+10.3%
Q3 FY2017Sep 30, 2017$202.09M–
Q2 FY2017Jun 30, 2017$226.43M–
Q1 FY2017Mar 31, 2017$151.51M–
Q4 FY2016Dec 31, 2016$164.81M–

More Wave Life Sciences figures

See a number that looks wrong?